Skip to main content

Table 4 Clinical outcome in cohort B: hCG administration on day 5

From: Intrauterine administration of human chorionic gonadotropin does not improve pregnancy and life birth rates independently of blastocyst quality: a randomised prospective study

 

Transfer with top blastocysts

Transfer with non-top blastocysts

Characteristics

hCG (n = 169)

culture medium (n = 188)

P-Value

hCG (n = 341)

culture medium (n = 306)

P-Value

Female age (years) mean ± s.d. (range)

36.1 ± 4.0 (22–43)

35.7 ± 4.3 (20–43)

0.331

37.6 ± 3.9 (27–43)

37.3 ± 4.2 (25–43)

0.330

Endometrium height (mm) mean ± s.d.

10.2 ± 1.5

9.9 ± 1.6

0.102

9.8 ± 1.7

9.7 ± 1.6

0.619

No. Embryos transferred Embryos / ET mean ± s.d.

274 1.6 ± 0.5

302 1.6 ± 0.5

0.781

594 1.7 ± 0.5

547 1.8 ± 0.4

0.208

Proportion of difficult ETs

10.7 %

9.0 %

0.610

10.6 %

10.8 %

0.926

No. Pregnancies (PR)

114 (67.5 %)

112 (59.6 %)

0.123

147 (43.1 %)

149 (48.7 %)

0.155

No. Clinical pregnancies (cPR)

100 (59.2 %)

103 (54.8 %)

0.404

113 (33.1 %)

125 (40.8 %)

0.042

No. Implanted embryos (IR)

123 (44.9 %)

128 (42.4 %)

0.545

130 (21.9 %)

148 (27.1 %)

0.042

No. Births (LBR)

90 (53.3 %)

91 (48.4 %)

0.360

98 (28.7 %)

107 (35.0 %)

0.089

No. Babies born

108

112

 

110

126

 

No. Miscarriages (MR)

10 (5.9 %)

12 (6.4 %)

0.855

15 (4.4 %)

18 (5.9 %)

0.392

  1. Numbers or percentages respectively are given in brackets, s.d.: standard deviation
  2. IVF characteristics and clinical outcome of cohort B. Miscarriage rate was defined as pregnancy loss after the detection of foetal heartbeat